Skip to content

EDIT - Editas Medicine, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Editas Medicine Inc

EDIT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

EDITEditas Medicine Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $4.54
52-wk low: $1.66
Prev close: $3.20
Mkt cap: $499.1M
Beta: 2.06
P/S: 10.6x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$77.5M

JS
Jim Simons
Q2 2026 13F
$8.0M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -157.3%
Market cap: $499M

Valuation

P/S10.62
P/B4.22

Quality

Operating margin-167.3%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: EDIT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $499.13M
Beta: 2.06

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

4.2x

Profit margin

-157.3%

Op margin

-167.3%

ROE

-118.8%

$6.6M

position

DS

D.E. Shaw

Q2 2026 13F

$6.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for EDIT

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.21

-$0.25 to -$0.19

Revenue expected

$3.7M

10 analysts

Last 30 days

4up0down

Analysts raising estimates

Estimate drift

+0.07

Change in 30 days

-118.8%

ROA-23.3%

Growth

Beta2.06